Pancreatic cancer drug fast-tracked by EU regulator
The European Medicines Agency (EMA) has begun an accelerated assessment of a potential new treatment for metastatic pancreatic cancer. Noting that pancreatic cancer is an area of high […]
The European Medicines Agency (EMA) has begun an accelerated assessment of a potential new treatment for metastatic pancreatic cancer. Noting that pancreatic cancer is an area of high […]
The National Institute for Health and Care Excellence (NICE) has issued thirteen Technology Appraisal decisions in June 2026, delivering nine positive recommendations, one updated recommendation, and two terminations. […]
EAHP Congress Highlights The timing of immunotherapy administration influences treatment effectiveness, with morning treatment associated with significantly better survival outcomes, according to new real-world data presented at the […]
EAHP Congress Highlights Continuous piperacillin/tazobactam infusion via elastomeric pump offers a safe, cost-effective alternative to inpatient antibiotic therapy in paediatric oncology, with measurable benefits for ward capacity, healthcare […]
A new study funded by the National Cancer Institute at the National Institutes of Health finds that how high school students perceive the costs of sun protection and the rewards of tanning […]
Despite recent advancements in breast cancer treatments, new breast cancer cases in women are predicted to rise by a third globally from 2.3 million in 2023 to more than 3.5 million in 2050. Similarly, yearly deaths […]
Some blood pressure medications can make the skin extra prone to sunburn. A registry study from Lund University in Sweden shows a possible increased risk of basal cell […]
Ninety-three percent of patients with a new cancer diagnosis were exposed to at least one type of misinformation about cancer treatments, a UF Health Cancer Center study has found. Most patients […]
Cancer care charity, Maggie’s, provides tailored support for cancer patients that complements clinical treatment. Founded in 1996 by Maggie Keswick-Jencks after she was told that she had recurrent […]
The European Medicines Agency (EMA) – the EU’s drug safety watchdog – approved 114 medicines last year, with 46 of these having a new active substance which had […]
Europe faces limited supplies of medicines containing radioisotopes which are used to diagnose or treat cancer, according to EU-level and national drug regulators. Experts say European countries should […]
Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000—until recently. Thanks to changes in Medicare Part […]